ENZN - Enzon Pharmaceuticals Inc.

$10.27 -0.07 | -0.68%
Today's Range: 10.23 - 10.47
ENZN Avg. Daily Volume: 183,414
12/16/09 - 4:00 PM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 10.27
52 Week High 10.80
52 Week Low 4.70
Avg. Daily Vol. (Mil) 0.73
Beta (3 year) 1.40
Share Related Items
Mkt Cap (Mil) 466.83
Shares Out (Mil) 45.46
Float (Mil) 44.18
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.20
Current Ratio 5.10
LT Debt/ Equity 4.68
Total Debt / Equity 4.68
Valuation Ratios
Price Earnings n.a.
Price/Sales 2.47
Price/Book 8.74
Price/Cash Flow 22.00
Per Share Data
Earnings 0.00
Sales 4.15
Book Value 1.17
Cash Flow 0.47
Business Summary
A biopharmaceutical company, which is dedicated to developing, manufacturing and commercializing important medicines for patients with cancer and other life-threatening conditions.
General Information
685 Route 202/206
Bridgewater, NJ 08807
www.enzon.com
Industry : Drugs
Sector: Health Care
Employees: 351
CEO: Jeffrey H. Buchalter
Short Interest
Current Month (Mil) 11.29
Previous Month (Mil) 11.22
Short Interest Ratio (Days) 17.30
Management Effectiveness
Return on Equity 1.50
Return on Assets 0.20
Return on Investments 0.30
Profitability
Gross Margin 83.40
EBIT Margin 6.20
Profit Margin 0.40
Latest ENZN Headlines

Brokerage Partners

TheStreet Premium Services

All Services